Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Influenza Vaccination After Myocardial Infarction (IAMI Trial): A Multicenter, Prospective, Randomized Controlled Clinical Trial Based on National Angiography and Angioplasty Registries

NCT02831608 is registered in ClinicalTrials.gov with Ole Frobert, MD, PhD as lead sponsor.

NCT NCT02831608
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02831608 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Influenza Vaccination After Myocardial Infarction (IAMI Trial): A Multicenter, Prospective, Randomized Controlled Clinical Trial Based on National Angiography and Angioplasty Registries
Lead sponsor
Ole Frobert, MD, PhD
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2016
Completion date
August 31, 2021
Enrollment
2,571 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure, influenza vaccines, influenza, human, myocardial infarction, stroke